Insmed, Inc. INSM
$123.74
-2.05%
at last close
Analyst Consensus
- Consensus Rating
- Buy (21 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $209.40
- Implied Upside
- +69.2%
- Price Target Range
- $169.00 – $245.00
- Analysts (12 mo)
- 21
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-10 | JP MorganJessica Fye |
Maintains | Overweight | $179 → $175 |
| 2026-08-10 | Truist SecuritiesDanielle Brill |
Reiterates | Buy | $185 → $195 |
| 2026-08-07 | GuggenheimVamil Divan |
Maintains | Buy | $207 → $205 |
| 2026-08-07 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $161 → $169 |
| 2026-08-07 | Evercore ISI GroupJosh Schimmer |
Maintains | Outperform | $160 → $170 |
| 2026-07-21 | BMO CapitalConnor Mackay |
Initiates coverage on | Outperform | $192 |
| 2026-07-15 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $160 → $161 |
| 2026-07-10 | GuggenheimVamil Divan |
Reiterates | Buy | $207 |
| 2026-06-22 | Evercore ISI GroupJosh Schimmer |
Maintains | Outperform | $162 → $160 |
| 2026-06-08 | JP MorganJessica Fye |
Maintains | Overweight | $180 → $179 |
| 2026-06-05 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $205 → $195 |
| 2026-05-14 | Truist SecuritiesDanielle Brill |
Maintains | Buy | $205 → $185 |
| 2026-05-08 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $220 → $205 |
| 2026-05-08 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $177 → $160 |
| 2026-05-08 | GuggenheimVamil Divan |
Maintains | Buy | $230 → $226 |
| 2026-04-17 | Roth CapitalAdam Walsh |
Reiterates | Buy | $212 |
| 2026-04-14 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $212 → $216 |
| 2026-04-01 | BarclaysEliana Merle |
Maintains | Overweight | $231 → $237 |
| 2026-03-30 | Morgan StanleyMatthew Harrison |
Upgrades | Equal-weight → Overweight | $166 → $212 |
| 2026-03-26 | HC Wainwright & Co.Andrew S. Fein |
Maintains | Buy | $230 → $245 |
| 2026-03-25 | MizuhoGraig Suvannavejh |
Maintains | Outperform | $204 → $206 |
| 2026-03-24 | Leerink PartnersJoseph Schwartz |
Maintains | Outperform | $210 → $215 |
| 2026-03-24 | StifelStephen Willey |
Maintains | Buy | $205 → $208 |
| 2026-03-24 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $175 → $177 |
| 2026-03-24 | B of A SecuritiesJason Zemansky |
Maintains | Buy | $211 → $213 |
| 2026-03-23 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $208 → $175 |
| 2026-03-16 | JefferiesFaisal Khurshid |
Assumes | Buy | $228 |
| 2026-02-24 | MizuhoGraig Suvannavejh |
Maintains | Outperform | $211 → $204 |
| 2026-02-23 | HC Wainwright & Co.Andrew S. Fein |
Reiterates | Buy | $230 |
| 2026-02-20 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $234 → $208 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $123.74
- Market Cap
- $28.89 billion
- 52-Week Range
- $90.39 – $212.75
- Average Volume
- 2.95 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.